Interim results from the Biogen Multiple Sclerosis Pregnancy Exposure Registry

Interim results have been published using data collected in the Biogen Multiple Sclerosis Pregnancy Exposure Registry. This latest study provides safety data for oral delayed-release dimethyl fumarate. More information can be found here.

Photo by Robina Weermeijer on Unsplash